Official Title
Impact of Zinc and Vitamin D3 Supplementation on the Survival of Institutionalized Aged Patients Infected With COVID-19
Brief Summary

Mortality from Covid-19 increases with age, reaching 14.8% from the age of 80. The severity of the infection is linked to the acute respiratory distress syndrome (ARDS) which requires intensive care. ARDS is the consequence of the reactional inflammatory storm that damages the lungs. Aged subjects are particularly prone to zinc and vitamin D deficiency. These two micronutrients are able to modulate the immune response by reducing the inflammatory storm. The hypothesis is that supplementation with zinc and vitamin D would reduce the inflammatory reaction which worsens ARDS and leads to the death of subjects infected with Covid-19.

Withdrawn
SARS-CoV 2

Dietary Supplement: Zinc gluconate

Zinc gluconate capsule 15 mg x 2 per day during 2 months

Dietary Supplement: 25-OH cholecalciferol

25-OH cholecalciferol drinkable solution 10 drops (2000 IU) per day during 2 months

Eligibility Criteria

Inclusion Criteria:

- Institutionalized

Exclusion Criteria:

- Life expectancy < 1 month independently of Covid-19 infection (overall subjects)

- Known hypercalcemia

- History of renal lithiasis

Eligibility Gender
All
Eligibility Age
Minimum: 60 Years ~ Maximum: N/A

David SEGUY, MD,PhD, Principal Investigator
University Hospital, Lille

University Hospital, Lille
NCT Number
Keywords
Survival
Covid-19
Aged subjects
Zinc
25-OH cholecalciferol
MeSH Terms
COVID-19
Cholecalciferol
Vitamin D